Michael Gleeson, SVP, Corporate Accounts at GenMark Diagnostics, Inc. (GNMK), sold 2,766 shares at $6.03 ($17K) on 2019-08-27, disclosed to the SEC on 2019-08-30.
Seasonal sale ($17k) by SVP, Corporate Accounts — this insider has traded GNMK in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| GNMK | SELL | 2021-02-22 | $51K | — | Filing → |
| GNMK | SELL | 2021-01-25 | $939K | — | Filing → |
| GNMK | SELL | 2020-11-25 | $43K | — | Filing → |